Literature DB >> 21992909

Diabetic ketoacidosis with L-asparaginase therapy.

Rakesh Mondal1, Madhumita Nandi, Astha Tiwari, Swati Chakravorti.   

Abstract

Diabetic ketoacidosisis as a complication of L-asparaginase therapy in children with acute leukemia is rare. Hyperglycemia may occur in about 10% of cases receiving Lasp, which may present as mild glucose intolerance to severe hyperglycemia. We report two children with acute lymphoblastic leukemia who developed diabetic ketoacidosis after treatment with L-asparaginase.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21992909

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  5 in total

Review 1.  Drug-Induced Hyperglycaemia and Diabetes.

Authors:  Neila Fathallah; Raoudha Slim; Sofien Larif; Houssem Hmouda; Chaker Ben Salem
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

2.  Acute Pancreatitis and Diabetic Ketoacidosis following L-Asparaginase/Prednisone Therapy in Acute Lymphoblastic Leukemia.

Authors:  Dania Lizet Quintanilla-Flores; Miguel Ángel Flores-Caballero; René Rodríguez-Gutiérrez; Héctor Eloy Tamez-Pérez; José Gerardo González-González
Journal:  Case Rep Oncol Med       Date:  2014-02-10

3.  L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha.

Authors:  Mousumee Panigrahi; Trupti Rekha Swain; Rabindra Kumar Jena; Ashutosh Panigrahi
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

4.  Diabetic ketoacidosis following PEG-asparaginase therapy

Authors:  Miriam Hinaa Ahmad; Ismat Shafiq
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-10-31

5.  Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.

Authors:  Patel Zeeshan Jameel; Sham Lohiya; Amol Dongre; Sachin Damke; Bhavana B Lakhkar
Journal:  BMC Pediatr       Date:  2020-05-18       Impact factor: 2.125
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.